Cited by 2,357Cardiac Ischemia and ReperfusionAcute Myocardial Infarction ResearchCardiac Fibrosis and Remodeling

Myocardial ischemia-reperfusion injury: a neglected therapeutic target

Open access
Hausenloy, Derek J., Yellon, Derek M.·2013·Journal of Clinical Investigation

Abstract

Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and limiting MI size is timely and effective myocardial reperfusion using either thombolytic therapy or primary percutaneous coronary intervention (PPCI). However, the process of reperfusion can itself induce cardiomyocyte death, known as myocardial reperfusion injury, for which there is still no effective therapy. A number of new therapeutic strategies currently under investigation for preventing myocardial reperfusion injury have the potential to improve clinical outcomes in patients with acute MI treated with PPCI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci62874

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nano drug delivery vehicles accumulate in injured tissue due to inflammation-mediated increased vascular permeability in myocardial IR.

    “In cases such as myocardial IR, nano drug delivery vehicles accumulate in the injured tissue due to inflammation-mediated increased vascular permeability.160”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

1 of the 115 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Schwartz LL, et al. New horizons in cardioprotec- tion: recommendations from the 2010 national heart, lung, and blood institute workshop. Circula- tion. 2011;124(10):1172-1179.

Cited by

Sorted by citations

Authors
Hausenloy, D. J., & Yellon, D. M.
Affiliations
University College London (GB)
Corresponding author
Yellon, Derek M.
Venue
Journal of Clinical Investigation
Published
2013-01-02
Volume
123
Issue
1
Pages
92-100
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2051395985
Cited by
2,357
References
115
Citations by year
2026: 176 · 2025: 177 · 2024: 226 · 2023: 218 · 2022: 236 · 2021: 231 · 2020: 240 · 2019: 226 · 2018: 172 · 2017: 124 · 2016: 130 · 2015: 101 · 2014: 69 · 2013: 28 · 2012: 1
FWCI
16.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0510-10164)
  • British Heart Foundation (RG/03/007, RG/08/015/26411, FS/06/023)
  • University College London
  • Medical Research Council (MR/K002066/1)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
myocardial ischemia-reperfusion injury, acute myocardial infarction, cardiomyocyte death, primary percutaneous coronary intervention, thrombolysis, therapeutic target, cardioprotection
MeSH terms
Animals, Humans, Myocardial Infarction, Myocardial Reperfusion Injury, Thrombolytic Therapy, Cell Death, Myocytes, Cardiac, Percutaneous Coronary Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review